Combination biologic therapy with interleukin-2 and interferon-alfa in the outpatient treatment of metastatic renal cell carcinoma

Semin Oncol. 1993 Dec;20(6 Suppl 9):11-5.

Authors

R A Figlin¹, W C Pierce, A Belldegrun

Affiliation

¹ Department of Medicine, Jonsson Comprehensive Cancer Center, UCLA School of Medicine 90024.

PMID: 8284686

No abstract available

Publication types

Review

MeSH terms

Ambulatory Care
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Carcinoma, Renal Cell / secondary
Carcinoma, Renal Cell / therapy*
Clinical Trials as Topic
Humans
Immunotherapy / methods
Interferon Type I / administration & dosage
Interferon Type I / therapeutic use*
Interferon-alpha / physiology
Interleukin-2 / administration & dosage
Interleukin-2 / physiology
Interleukin-2 / therapeutic use*
Kidney Neoplasms / therapy*
Killer Cells, Lymphokine-Activated
Lymphocytes, Tumor-Infiltrating
Recombinant Proteins / administration & dosage
Recombinant Proteins / therapeutic use

Substances

Interferon Type I
Interferon-alpha
Interleukin-2
Recombinant Proteins